In a letter to states and other grant recipients, the Trump administration says the strips encourage drug use.
A panel convened in July 2025 by the Food and Drug Administration sparked controversy by casting doubt about the safety of commonly used antidepressants during pregnancy. But it also raised the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results